ARTICLE | Company News
G-Con LLC, iBio deal
March 8, 2010 8:00 AM UTC
iBio agreed in principle to license G-Con its iBioLaunch technology to develop influenza vaccines. iBioLaunch is a plant-based protein production system. Further terms were not disclosed. ...